International Stem Cell (ISCO)
OTHER OTC:ISCO
Want to see ISCO full AI Analyst Report?
Total Valuation
International Stem Cell has a market cap or net worth of $1.48M. The enterprise value is $724.75K.
Market Cap$1.48M
Enterprise Value$724.75K
Share Statistics
International Stem Cell has 8,004,389 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,004,389
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
International Stem Cell’s return on equity (ROE) is -1.74 and return on invested capital (ROIC) is -6.72%.
Return on Equity (ROE)-1.74
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)-6.72%
Return on Capital Employed (ROCE)-1.11
Revenue Per Employee284.38K
Profits Per Employee-13.06K
Employee Count32
Asset Turnover1.89
Inventory Turnover2.66
Valuation Ratios
The current PE Ratio of International Stem Cell is ―. International Stem Cell’s PEG ratio is -0.03.
PE Ratio―
PS Ratio0.12
PB Ratio-0.28
Price to Fair Value-0.28
Price to FCF-32.02
Price to Operating Cash Flow-13.89
PEG Ratio-0.03
Income Statement
In the last 12 months, International Stem Cell had revenue of 9.10M and earned -418.00K in profits. Earnings per share was -0.05.
Revenue9.10M
Gross Profit5.07M
Operating Income-267.00K
Pretax Income-418.00K
Net Income-418.00K
EBITDA-48.00K
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -98.00K and capital expenditures -61.00K, giving a free cash flow of -159.00K billion.
Operating Cash Flow-98.00K
Free Cash Flow-159.00K
Free Cash Flow per Share-0.02
Dividends & Yields
International Stem Cell pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.15
52-Week Price Change8.82%
50-Day Moving Average0.16
200-Day Moving Average0.15
Relative Strength Index (RSI)56.17
Average Volume (3m)2.04K
Important Dates
International Stem Cell upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
International Stem Cell as a current ratio of 0.74, with Debt / Equity ratio of -83.49%
Current Ratio0.74
Quick Ratio0.41
Debt to Market Cap2.98
Net Debt to EBITDA-57.08
Interest Coverage Ratio-1.77
Taxes
In the past 12 months, International Stem Cell has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
International Stem Cell EV to EBITDA ratio is -80.43, with an EV/FCF ratio of -110.30.
EV to Sales0.42
EV to EBITDA-80.43
EV to Free Cash Flow-110.30
EV to Operating Cash Flow482.58
Balance Sheet
International Stem Cell has $933.00K in cash and marketable securities with $3.52M in debt, giving a net cash position of -$2.59M billion.
Cash & Marketable Securities$933.00K
Total Debt$3.52M
Net Cash-$2.59M
Net Cash Per Share-$0.32
Tangible Book Value Per Share-$0.59
Margins
Gross margin is 56.98%, with operating margin of -2.93%, and net profit margin of -4.59%.
Gross Margin56.98%
Operating Margin-2.93%
Pretax Margin-4.59%
Net Profit Margin-4.59%
EBITDA Margin-0.53%
EBIT Margin-2.93%
Analyst Forecast
The average price target for International Stem Cell is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast2.21%
EPS Growth Forecast-53.25%